State of the art in the diagnosis and management of interstitial lung disease

Authors

  • Maria T. A. Buzan
  • Carmen Monica Pop

DOI:

https://doi.org/10.15386/cjmed-457

Keywords:

interstitial lung disease, pulmonary fibrosis, usual interstitial pneumonia, nonspecific interstitial pneumonia, diagnosis

Abstract

The interstitial lung diseases (ILDs) are a diverse group of disorders characterized by a varying combination of inflammation and fibrosis of the pulmonary parenchyma. Treatment and prognosis of ILD typically depend on the underlying ILD subtype, highlighting the importance of accurate classification and diagnosis. Besides a thorough history and clinical examination, the protocol should include a 6-minute walk test, chest radiography, high-resolution computed tomography, biochemical analysis, pulmonary function tests, blood gas analysis, bronchoalveolar lavage, and, when necessary, a lung biopsy. The final diagnosis of ILD entities requires dynamic interaction between clinicians, radiologists and pathologists to reach a clinico-radiologic-pathologic diagnosis, the gold standard no longer being the histology but rather a multidisciplinary approach.

Author Biographies

Maria T. A. Buzan, Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

Departmentof Pulmonology

Carmen Monica Pop, Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

Departmentof Pulmonology

Downloads

Additional Files

Published

2015-04-29

How to Cite

1.
Buzan MTA, Pop CM. State of the art in the diagnosis and management of interstitial lung disease. Med Pharm Rep [Internet]. 2015 Apr. 29 [cited 2025 Oct. 5];88(2):116-23. Available from: https://medpharmareports.com/index.php/mpr/article/view/457

Issue

Section

Reviews